Thyroid Cancer Clinical Trial
Official title:
The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy
NCT number | NCT03375931 |
Other study ID # | 4-2017-0251 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | December 15, 2017 |
Est. completion date | May 2020 |
physiological end-point, incidence of adverse events, and changes in psychological status.
In the past, physiological goals, major morbidity and mortality were used as indicators of
recovery after surgery. However, major morbidity and mortality rates were extremely low due
to the development of surgery and anesthesia techniques, and measurements of these indicators
do not adequately reflect postoperative recovery. On the other hand, the measurement of the
patient's health status or quality of life has become an important metric in many clinical
studies. The Quality of Recovery 40 Questionnaire (QoR-40) is a multidimensional tool that
specifically assesses and develops anesthetic and postoperative health conditions. Severance
Hospital is conducting an anesthesiologist-led prayer for the patient only for the desired
patient before anesthesia. Although it may be expected that this preoperative airway may
improve the quality of recovery after anesthesia / surgery by reducing patient anxiety, there
is no objective study on this. The aim of this study was to investigate the effect of
preoperative preoperative airway on the quality of postoperative recovery in patients who
underwent thyroidectomy for thyroid cancer. I want to see. In addition, we will investigate
whether preoperative airway affects sympathetic nervous system during surgery.
Status | Recruiting |
Enrollment | 36 |
Est. completion date | May 2020 |
Est. primary completion date | May 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - patients between 20 and 70 years old under ASA 3. - obtaining written informed consent from the patients who were undergoing thyroidectomy. - weights under 90 kg and BMI under 30 Exclusion Criteria: - emergency operation - re-operation - combined surgery over 4 departments - cardiac disease (unstable angina, congestive heart failure, valvular heart disease) - Ventricular conduction abnormality - prior pacemaker insertion - uncontrolled hypertension (diastolic blood pressure > 110mmHg) - bradycardia (HR < 40 Bpm) - cerebral vascular disease (cerebral hemorrhage, cerebral ischemia) - hepatic or renal failure - patients who take antiarrythmic agent - neurological or psychiatric illnesses - foreigner and patient who can not read the letter |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine | Seoul |
Lead Sponsor | Collaborator |
---|---|
Yonsei University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | QoR40 on POD1 | On the first day after surgery, visit the patient and give the QoR 40 to the patient to fill out a questionnaire. | within the first 1 day after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
Withdrawn |
NCT04224792 -
Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors
|
N/A | |
Completed |
NCT01728623 -
A Study of E7080 in Subjects With Advanced Thyroid Cancer
|
Phase 2 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT02911155 -
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
|
||
Recruiting |
NCT05025046 -
NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
|
||
Not yet recruiting |
NCT03978351 -
The Role of Midkine in Diagnosis of Thyroid Cancer
|
||
Completed |
NCT02658513 -
Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
|
||
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Withdrawn |
NCT01994200 -
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
|
Phase 1/Phase 2 | |
Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
Terminated |
NCT01403324 -
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
|
N/A | |
Completed |
NCT00970359 -
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
|
N/A | |
Completed |
NCT00439478 -
Dental Safety Profile of High-Dose Radioiodine Therapy
|
Phase 4 | |
Completed |
NCT00223158 -
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
|
N/A | |
Active, not recruiting |
NCT04544111 -
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
|
Phase 2 | |
Completed |
NCT04876287 -
Salivary dysfuncTion After Radioiodine Treatment
|
||
Recruiting |
NCT06073223 -
Intervention to Decrease Overtreatment of Patients With Low-risk Thyroid Cancer
|
N/A | |
Recruiting |
NCT06037174 -
Comparison of Quality of Life in Patients With Differentiated Thyroid Carcinoma Undergoing Different Surgery
|
||
Recruiting |
NCT04952493 -
Anlotinib or Penpulimab in Combination With RAI for DTC
|
Phase 2 |